Veeda Clinical Research
Ticker > Company >

Veeda Clinical Research share price

Veeda Clinical Research Ltd.

 874   0   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year32.25%
3 Year25.1%
5 Year10.17%

Profit Growth

1 Year41.57%
3 Year746.02%
5 Year-3.44%

ROE%

1 Year5.36%
3 Year26.4%
5 Year33.05%

ROCE %

1 Year8.53%
3 Year25.97%
5 Year32.36%

Debt/Equity

0

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has shown a good revenue growth of 25.0977915197566% for the Past 3 years.
  • Company has been maintaining healthy ROE of 26.404052468944% over the past 3 years.
  • Company has been maintaining healthy ROCE of 25.9734135859906% over the past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • Company has contingent liabilities of 134.307 Cr.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 218.44 151.27 195.81 223.93 296.15
Total Expenditure 136.14 131.89 129.1 182.85 241.74
Operating Profit 82.31 19.39 66.72 41.08 54.42
Other Income 5.34 2.41 38.57 4.23 9.15
Interest 2.38 5.09 4.81 4.58 5.33
Depreciation 9.44 15.8 14.95 15.53 21.13
Exceptional Items 0 0 0 0 0
Profit Before Tax 75.82 0.9 85.53 25.2 37.1
Tax 23.2 0.94 22.25 6.87 11.15
Net Profit 52.62 -0.04 63.29 18.33 25.95
Adjusted EPS (Rs.) 7.57 -0.01 17.55 3.47 4.91

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 35.82 35.82 35.83 10.58 10.58
Total Reserves 53.69 52.18 133.93 463.18 510.6
Borrowings 0 0 0 0 0
Other N/C liabilities -0.17 32.47 34.8 27.48 34.54
Current liabilities 39.82 55.57 74.75 88.68 96.4
Total Liabilities 129.17 176.04 279.31 589.91 652.11
Assets
Net Block 37.75 77.66 74.36 69.7 105.72
Capital WIP 7.41 0 0.46 8.84 4.69
Intangible WIP 0.33 0.51 0.67 1.37 3.32
Investments 0 0 37.02 165.13 213.15
Loans & Advances 10.43 17.58 41.38 26.02 25.91
Other N/C Assets 0.4 4.85 4.89 13.7 36.51
Current Assets 72.84 75.44 120.52 305.16 262.82
Total Assets 129.17 176.04 279.31 589.91 652.11
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023
Profit from operations 25.2 37.1
Adjustment 20.9 32.45
Changes in Assets & Liabilities -21.41 19.07
Tax Paid -11.96 -13.55
Operating Cash Flow 12.73 75.06
Investing Cash Flow -142.07 -107.61
Financing Cash Flow 172.1 8.15
Net Cash Flow 42.76 -24.4

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about Veeda Clinical Research
X